David Lamond - Insider Trading & Ownership

Entity
Individual
Location
C/O Cortexyme, Inc., 269 East Grand Ave., South San Francisco, California
Summary
The estimated net worth of David Lamond is at least $6.18 M dollars as of June 7, 2024. David Lamond is the Director of Quince Therapeutics, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $6 M. David Lamond is the Director of Applied Molecular Transport Inc. and owns shares of Applied Molecular Transport Inc. (AMTI) stock worth about $176 K.
All Insider Reports
All Insider Reports

Ownership of David Lamond

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QNCX Quince Therapeutics, Inc. Director $6 M +$602 K +11.1% Jun 5, 2024
AMTI Applied Molecular Transport Inc. Director $176 K May 24, 2022
LHDXQ Lucira Health, Inc. Director Jun 1, 2022

Insider Transactions Reported by David Lamond:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership